Core Viewpoint - CVS Group reported a successful year of growth, with improved operations in the U.K. and continued expansion in Australia, positioning the company well for future success [2]. Financial Performance - Revenue increased by 5.4% to GBP 673.2 million, despite a challenging start to the year with a like-for-like sales decline of 1.1% in the first half [3]. - Adjusted EBITDA rose by 9.4% to GBP 134.6 million, driven by acquisitions and disciplined cost management, with an adjusted EBITDA margin increase of 70 basis points to 20% [3]. Strategic Actions - The sale of the crematoria business in May 2025 was executed at an attractive 10x EBITDA multiple, providing capital for selective organic investments in the U.K. and expansion in Australia [4].
CVS Group plc (CVSGF) Q4 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha·2025-10-07 11:15